Sign in
4

Changes in Ownership

Coherus Oncology, Inc. Filed Acc 0001209191-14-067906

Director acquired 26,505 shares (option exercise)

  • Director acquired 55,287 shares (conversion)
  • Director disposed of 2,956 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Richards Christos · Director

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2014-11-12 Option exercise : show line 1 in the form +26,505 $1.67 $44,184 26,505 D
2014-11-12 Other disposition : show line 2 in the form −2,956 23,549 D
2014-11-12 Conversion : show line 3 in the form +39,991 63,540 D
2014-11-12 Conversion : show line 4 in the form +12,672 76,212 D
2014-11-12 Conversion : show line 5 in the form +2,624 78,836 D

Table II: Derivative

7 lines
Date Transaction Shares Price Value Owned after D/I
2014-11-12 Option exercise : show line 6 in the form Warrant to Purchase Common Stock −26,505 0 D
2014-11-12 Option exercise : show line 7 in the form Warrant to Purchase Series B Preferred Stock −429 0 D
2014-11-12 Option exercise : show line 8 in the form Series B Preferred Stock +429 $0.02 $7 12,673 D
2014-11-12 Other disposition : show line 9 in the form Series B Preferred Stock −1 12,672 D
2014-11-12 Conversion : show line 10 in the form Series A Preferred Stock −39,991 0 D
2014-11-12 Conversion : show line 11 in the form Series B Preferred Stock −12,672 0 D
2014-11-12 Conversion : show line 12 in the form Series C Preferred Stock −2,624 0 D
Loading xslF345X03/doc4.xml…